In Vitro Measurement of Regional Nasal Drug Delivery with Flonase, ® Flonase ® Sensimist,™ and MAD Nasal™ in Anatomically Correct Nasal Airway Replicas of Pediatric and Adult Human Subjects
- 5 December 2019
- journal article
- research article
- Published by SAGE Publications in Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Vol. 32 (6) , 374-385
Abstract
Background: The majority of current nasal delivery devices, commercialized for children, are developed for adults. Differences in the dose reaching the target are expected due to significant differences between the pediatric and adult nasal airway geometries and their inhalation patterns. This study aims to compare the efficacy of most common nasal drug delivery devices in terms of regional delivery of suspension and solution formulations in pediatric and adult subjects. Methods: Anatomically correct nasal models of 2-, 5-, and 50-year old subjects were developed to evaluate regional nasal delivery of suspensions of fluticasone propionate and fluticasone furoate delivered with Flonase ® and Flonase ® Sensimist™, respectively, and the delivery of an aqueous solution of a model drug, administered with MAD Nasal™. Relevant inhalation patterns were considered for each nasal airway geometry. Controlled administration methods were used, and all contributing parameters, including particle size, velocity, and plume geometry, are reported. Results: Regional deposition patterns resulting from Flonase ® Sensimist™ and Flonase ® were not significantly different in each replica ( p > 0.05), despite their different plume geometry and droplet size distributions. However, there was a significant difference in deposition of nasal sprays between the pediatric (2- and 5-year old) and adult models ( p < 0.05), while no statistical differences were found between the two pediatric models ( p > 0.05). The MAD atomizer resulted in different deposition patterns in all three subjects ( p < 0.05). Conclusion: Nasal sprays are not adequate delivery devices for pediatric population, due to the narrower nasal passage and greater anterior deposition (∼60%). MAD atomizer resulted in significantly less anterior deposition (∼10%–15%) compared to the nasal pumps, but there was ∼30% run off to the throat. An in vitro platform incorporating anatomically correct nasal geometries and inhalation patterns can guide the development of age-appropriate nasal drug delivery devices.Keywords
This publication has 32 references indexed in Scilit:
- Visualization and Quantification of Nasal and Olfactory Deposition in a Sectional Adult Nasal Airway CastPharmaceutical Research, 2016
- Nasal drug delivery devices: characteristics and performance in a clinical perspective—a reviewDrug Delivery and Translational Research, 2012
- The Influence of Spray Properties on Intranasal DepositionJournal of Aerosol Medicine, 2007
- Characterization of Deposition from Nasal Spray Devices Using A Computational Fluid Dynamics Model of The Human Nasal PassagesJournal of Aerosol Medicine, 2007
- The Effect of Formulation Variables and Breathing Patterns on the Site of Nasal Deposition in an Anatomically Correct ModelPharmaceutical Research, 2005
- The assessment of topical nasal drug distributionClinical Otolaryngology, 2004
- Comparison of Nasal Deposition and Clearance of Aerosol Generated by a Nebulizer and an Aqueous Spray PumpPharmaceutical Research, 1999
- Nasal delivery systems and their effect on deposition and absorptionAdvanced Drug Delivery Reviews, 1998
- The nasal distribution of metered does inhalersThe Journal of Laryngology & Otology, 1987
- Distribution and removal of human serum albumin‐technetium 99m instilled intranasally.British Journal of Clinical Pharmacology, 1976